Other languages AstraZeneca PLC Xetra

Equities

ZEG

GB0009895292

Market Closed - Xetra Other stock markets 16:35:31 07/06/2024 BST			5-day change	1st Jan Change
148.2 ^EUR	0.00%		+3.42%	+21.42%

06-07	ASTRAZENECA : JP Morgan reiterates its Buy rating	ZD
06-05	Department of Health - Abu Dhabi and AstraZeneca Expand Partnership During Bio International Convention 2024 to Establish New Rare Diseases Centre of Excellence	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LA CIFRA - 64 000 millones, ¿el valor de Shein en el momento de su salida a bolsa?	06-06
Department of Health - Abu Dhabi and AstraZeneca Expand Partnership During Bio International Convention 2024 to Establish New Rare Diseases Centre of Excellence	06-05
Berenberg raises Taylor Wimpey to 'buy'	06-05
AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase	06-05
AstraZeneca : l'acquisition de Fusion est finalisée	06-05
AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal	06-05
Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete	06-04
ASTRAZENECA : UBS réitère son conseil après l'ASCO	06-04
AstraZeneca : le CHMP recommande d'approuver Tagrisso en UE	06-03
AstraZeneca's Tagrisso Reduces Lung Cancer Progression in Phase 3 Trial	06-03
AstraZeneca : Tagrisso prometteur dans le cancer du poumon	06-03
AstraZeneca Says Imfinzi Reduced Risk of Death for Small-Cell Lung Cancer Patients	06-03
AstraZeneca : essai concluant dans le cancer du poumon	06-03
AstraZeneca cancer treatment Tagrisso recommended for approval in EU	06-03
AstraZeneca : essai concluant pour Enhertu en cancer du sein	06-03
AstraZeneca Says Potential Breast Cancer Treatment Reduces Risk of Disease Progression by up to 38%	06-03
Fais-nous rêver, Christine	06-03
En Direct des Marchés : Sanofi, Airbus, Thales, Atos, Casino, Tesla, Aramco, Valneva...	06-03
AstraZeneca's Tagrisso Secures Recommendation for EU Approval for Advanced Lung Cancer with Chemotherapy	06-03
AstraZeneca's Tagrisso (Osimertinib) Announces the Addition of Pemetrexed and Platinum-Based Chemotherapy Recommended for Approval in the European Union for 1St-Line Treatment of Adult Patients	06-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm